Clinical Trial Update: Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a multi-drug first-line regimen including liposomal irinotecan, fluorouracil, leucovorin, vermofenib, and cetuximab for BRAFV600E-mut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• Onivyde (irinotecan hydrochloride liposome injection)
• Vermofenib (vermofenib)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Carcinoma | Phase 2 | Status: RECRUITING